You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 1, 2024

CLINICAL TRIALS PROFILE FOR CALDOLOR


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for Caldolor

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00225706 ↗ A Study of Caldolor in Hospitalized Febrile Pediatric Patients Completed Cumberland Pharmaceuticals Phase 3 2005-10-01 The primary objective of this study of Caldolor administered to febrile hospitalized pediatric patients every 6 hours for 24 hours is to determine the clinical equivalence of a single dose of Caldolor compared to acetaminophen (paracetamol; APAP) for the treatment of fever as measured by the AUC Tº within the first 6 hours of treatment (as compared to a target temperature of 98.6ºF [37.0ºC]).
NCT00225732 ↗ Trial of Caldolor for Treatment of Pain in Post-Operative Adult Patients Completed Cumberland Pharmaceuticals Phase 3 2005-01-01 The primary objective of this study of Caldolor (IV ibuprofen) administered to post-operative hospitalized adult patients every 6 hours for 48 hours is to determine the efficacy of Caldolor compared to placebo for the treatment of post-operative pain as measured by reduction in the requirement for the narcotic analgesic, morphine, post surgery
NCT00470600 ↗ Efficacy and Safety Study of Caldolor (IV Ibuprofen) in Hospitalized Adult Orthopedic Patients Completed Cumberland Pharmaceuticals Phase 3 2007-05-01 The primary objective of this study of Caldolor (IV ibuprofen) administered to post-operative hospitalized adult orthopedic patients every 6 hours for at least 24 hours is to determine the efficacy of Caldolor (IV ibuprofen) compared to placebo for the treatment of post-operative pain by patients self-assessment of pain.
NCT00606489 ↗ Efficacy and Safety Study of Caldolor (Intravenous Ibuprofen) in Hospitalized Adult and Pediatric Burn Patients Completed Cumberland Pharmaceuticals Phase 3 2007-11-01 The primary objective of this study of Caldolor administered to hospitalized adult and pediatric burn patients is to determine the efficacy of Caldolor on reducing fever when compared to placebo when administered every 6 hours for at least 24 hours.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Caldolor

Condition Name

Condition Name for Caldolor
Intervention Trials
Pain 8
Fever 3
Biliary Colic 1
Inguinal Hernia 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Caldolor
Intervention Trials
Pain, Postoperative 5
Fever 3
Hyperthermia 2
Hemorrhage 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Caldolor

Trials by Country

Trials by Country for Caldolor
Location Trials
United States 56
Korea, Republic of 3
India 3
South Africa 2
Panama 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Caldolor
Location Trials
Florida 5
Arizona 4
Ohio 4
New York 4
Pennsylvania 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Caldolor

Clinical Trial Phase

Clinical Trial Phase for Caldolor
Clinical Trial Phase Trials
Phase 4 11
Phase 3 5
Phase 2 3
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Caldolor
Clinical Trial Phase Trials
Completed 16
Terminated 4
Unknown status 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Caldolor

Sponsor Name

Sponsor Name for Caldolor
Sponsor Trials
Cumberland Pharmaceuticals 11
St. Joseph's Hospital and Medical Center, Phoenix 2
Seoul National University Hospital 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Caldolor
Sponsor Trials
Other 16
Industry 11
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.